Isocaloric manipulation of macronutrients within a high-carbohydrate/moderate-fat diet induces unique effects on hepatic lipogenesis, steatosis and liver injury

Journal of Nutritional Biochemistry

Volumn 29, Issue , 2016, Pages 12-20

  Pierce, Andrew A ^a,b   Duwaerts, Caroline C ^a,b   Soon, Russell K ^a,b   Siao, Kevin ^a,b   Grenert, James P ^a,b   Fitch, Mark ^c,d   Hellerstein, Marc K ^c,d   Beysen, Carine ^d   Turner, Scott M ^d   Maher, Jacquelyn J ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d KINEMED INC   (United States)

Author keywords

Fatty liver; Palmitate; Saturated fat; Steatohepatitis; Sucrose; Sugar; Triglyceride

Indexed keywords

CARBOHYDRATE DIET; FAT INTAKE;

ADMINISTRATION AND DOSAGE; ANIMAL; C3H MOUSE; CALORIC INTAKE; CARBOHYDRATE DIET; FAT INTAKE; FATTY LIVER; INJURIES; LIPOGENESIS; LIVER; MALE; METABOLISM; MOUSE;

ANIMALS; DIETARY CARBOHYDRATES; DIETARY FATS; ENERGY INTAKE; FATTY LIVER; LIPOGENESIS; LIVER; MALE; MICE; MICE, INBRED C3H;

EID: 84958180587     PISSN: 09552863     EISSN: 18734847     Source Type: Journal    
DOI: 10.1016/j.jnutbio.2015.10.020     Document Type: Article

References (59)

1. Samocha-Bonet D., Dixit V.D., Kahn C.R., Leibel R.L., Lin X., Nieuwdorp M., et al. Metabolically healthy and unhealthy obese - the 2013 Stock Conference report. Obes Rev 2014, 15:697-708.
2. Browning J.D., Szczepaniak L.S., Dobbins R., Nuremberg P., Horton J.D., Cohen J.C., et al. Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity. Hepatology 2004, 40:1387-1395.
3. Tetri L.H., Basaranoglu M., Brunt E.M., Yerian L.M., Neuschwander-Tetri B.A. Severe NAFLD with hepatic necroinflammatory changes in mice fed trans fats and a high-fructose corn syrup equivalent. Am J Physiol Gastrointest Liver Physiol 2008, 295:G987-G995.
4. Kohli R., Kirby M., Xanthakos S.A., Softic S., Feldstein A.E., Saxena V., et al. High-fructose, medium chain trans fat diet induces liver fibrosis and elevates plasma coenzyme Q9 in a novel murine model of obesity and nonalcoholic steatohepatitis. Hepatology 2010, 52:934-944.
5. Charlton M., Krishnan A., Viker K., Sanderson S., Cazanave S., McConico A., et al. Fast food diet mouse: novel small animal model of NASH with ballooning, progressive fibrosis, and high physiological fidelity to the human condition. Am J Physiol Gastrointest Liver Physiol 2011, 301:G825-G834.
6. Savard C., Tartaglione E.V., Kuver R., Haigh W.G., Farrell G.C., Subramanian S., et al. Synergistic interaction of dietary cholesterol and dietary fat in inducing experimental steatohepatitis. Hepatology 2013, 57:81-92.
7. Mells J.E., Fu P.P., Kumar P., Smith T., Karpen S.J., Anania F.A. Saturated fat and cholesterol are critical to inducing murine metabolic syndrome with robust nonalcoholic steatohepatitis. J Nutr Biochem 2015, 26:285-292.
8. Yao Z.M., Vance D.E. The active synthesis of phosphatidylcholine is required for very low density lipoprotein secretion from rat hepatocytes. J Biol Chem 1988, 263:2998-3004.
9. Vance J.E., Vance D.E. The role of phosphatidylcholine biosynthesis in the secretion of lipoproteins from hepatocytes. Can J Biochem Cell Biol 1985, 63:870-881.
10. Leclercq I.A., Farrell G.C., Field J., Bell D.R., Gonzalez F.J., Robertson G.R. CYP2E1 and CYP4A as microsomal catalysts of lipid peroxides in murine nonalcoholic steatohepatitis. J Clin Invest 2000, 105:1067-1075.
11. Rizki G., Arnaboldi L., Gabrielli B., Yan J., Lee G.S., Ng R.K., et al. Mice fed a lipogenic methionine-choline-deficient diet develop hypermetabolism coincident with hepatic suppression of SCD-1. J Lipid Res 2006, 47:2280-2290.
12. Pickens M.K., Yan J.S., Ng R.K., Ogata H., Grenert J.P., Beyson C., et al. Dietary sucrose is essential to the development of liver injury in the MCD model of steatohepatitis. J Lipid Res 2009, 50:2072-2082.
13. Pickens M.K., Ogata H., Soon R.K., Grenert J.P., Maher J.J. Dietary fructose exacerbates hepatocellular injury when incorporated into a methionine-choline-deficient diet. Liver Int 2010, 30:1229-1239.
14. Kleiner D.E., Brunt E.M., Van Natta M., Behling C., Contos M.J., Cummings O.W., et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 2005, 41:1313-1321.
15. Lackner C., Gogg-Kamerer M., Zatloukal K., Stumptner C., Brunt E.M., Denk H. Ballooned hepatocytes in steatohepatitis: the value of keratin immunohistochemistry for diagnosis. J Hepatol 2008, 48:821-828.
16. Folch J., Lees M., Sloane Stanley G.H. A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem 1957, 226:497-509.
17. Lee G.S., Yan J.S., Ng R.K., Kakar S., Maher J.J. Polyunsaturated fat in the methionine-choline-deficient diet influences hepatic inflammation but not hepatocellular injury. J Lipid Res 2007, 48:1885-1896.
18. Hellerstein M.K., Christiansen M., Kaempfer S., Kletke C., Wu K., Reid J.S., et al. Measurement of de novo hepatic lipogenesis in humans using stable isotopes. J Clin Invest 1991, 87:1841-1852.
19. Hellerstein M.K., Kletke C., Kaempfer S., Wu K., Shackleton C.H. Use of mass isotopomer distributions in secreted lipids to sample lipogenic acetyl-CoA pool in vivo in humans. Am J Physiol 1991, 261:E479-E486.
20. Hellerstein M.K., Neese R.A. Mass isotopomer distribution analysis at eight years: theoretical, analytic, and experimental considerations. Am J Physiol 1999, 276:E1146-E1170.
21. Jones P.J. Tracing lipogenesis in humans using deuterated water. Can J Physiol Pharmacol 1996, 74:755-760.
22. 2O and mass isotopomer analysis. Am J Physiol 1994, 266:E699-E708.
23. Vedala A., Wang W., Neese R.A., Christiansen M.P., Hellerstein M.K. Delayed secretory pathway contributions to VLDL-triglycerides from plasma NEFA, diet, and de novo lipogenesis in humans. J Lipid Res 2006, 47:2562-2574.
24. Peter A., Cegan A., Wagner S., Lehmann R., Stefan N., Konigsrainer A., et al. Hepatic lipid composition and stearoyl-coenzyme A desaturase 1 mRNA expression can be estimated from plasma VLDL fatty acid ratios. Clin Chem 2009, 55:2113-2120.
25. Flowers M.T. The delta9 fatty acid desaturation index as a predictor of metabolic disease. Clin Chem 2009, 55:2071-2073.
26. Matsuzawa N., Takamura T., Kurita S., Misu H., Ota T., Ando H., et al. Lipid-induced oxidative stress causes steatohepatitis in mice fed an atherogenic diet. Hepatology 2007, 46:1392-1403.
27. Monetti M., Levin M.C., Watt M.J., Sajan M.P., Marmor S., Hubbard B.K., et al. Dissociation of hepatic steatosis and insulin resistance in mice overexpressing DGAT in the liver. Cell Metab 2007, 6:69-78.
28. Ishimoto T., Lanaspa M.A., Rivard C.J., Roncal-Jimenez C.A., Orlicky D.J., Cicerchi C., et al. High-fat and high-sucrose (western) diet induces steatohepatitis that is dependent on fructokinase. Hepatology 2013, 58:1632-1643.
29. Jiang J.X., Chen X., Fukada H., Serizawa N., Devaraj S., Torok N.J. Advanced glycation endproducts induce fibrogenic activity in nonalcoholic steatohepatitis by modulating TNF-alpha-converting enzyme activity in mice. Hepatology 2013, 58:1339-1348.
30. Ouyang X., Cirillo P., Sautin Y., McCall S., Bruchette J.L., Diehl A.M., et al. Fructose consumption as a risk factor for non-alcoholic fatty liver disease. J Hepatol 2008, 48:993-999.
31. Zelber-Sagi S., Nitzan-Kaluski D., Goldsmith R., Webb M., Blendis L., Halpern Z., et al. Long term nutritional intake and the risk for non-alcoholic fatty liver disease (NAFLD): a population based study. J Hepatol 2007, 47:711-717.
32. Abdelmalek M.F., Suzuki A., Guy C., Unalp-Arida A., Colvin R., Johnson R.J., et al. Increased fructose consumption is associated with fibrosis severity in patients with nonalcoholic fatty liver disease. Hepatology 2010, 51:1961-1971.
33. Tappy L., Le K.A. Does fructose consumption contribute to non-alcoholic fatty liver disease?. Clin Res Hepatol Gastroenterol 2012, 36:554-560.
34. Chung M., Ma J., Patel K., Berger S., Lau J., Lichtenstein A.H. Fructose, high-fructose corn syrup, sucrose, and nonalcoholic fatty liver disease or indexes of liver health: a systematic review and meta-analysis. Am J Clin Nutr 2014, 100:833-849.
35. Chiu S., Sievenpiper J.L., de Souza R.J., Cozma A.I., Mirrahimi A., Carleton A.J., et al. Effect of fructose on markers of non-alcoholic fatty liver disease (NAFLD): a systematic review and meta-analysis of controlled feeding trials. Eur J Clin Nutr 2014, 68:416-423.
36. Kanerva N., Sandboge S., Kaartinen N.E., Mannisto S., Eriksson J.G. Higher fructose intake is inversely associated with risk of nonalcoholic fatty liver disease in older Finnish adults. Am J Clin Nutr 2014, 100:1133-1138.
37. Moore J.B., Gunn P.J., Fielding B.A. The role of dietary sugars and de novo lipogenesis in non-alcoholic fatty liver disease. Nutrients 2014, 6:5679-5703.
38. Rosqvist F., Iggman D., Kullberg J., Cedernaes J., Johansson H.E., Larsson A., et al. Overfeeding polyunsaturated and saturated fat causes distinct effects on liver and visceral fat accumulation in humans. Diabetes 2014, 63:2356-2368.
39. Musso G., Gambino R., De Michieli F., Cassader M., Rizzetto M., Durazzo M., et al. Dietary habits and their relations to insulin resistance and postprandial lipemia in nonalcoholic steatohepatitis. Hepatology 2003, 37:909-916.
40. Musso G., Gambino R., Pacini G., De Michieli F., Cassader M. Prolonged saturated fat-induced, glucose-dependent insulinotropic polypeptide elevation is associated with adipokine imbalance and liver injury in nonalcoholic steatohepatitis: dysregulated enteroadipocyte axis as a novel feature of fatty liver. Am J Clin Nutr 2009, 89:558-567.
41. Da Silva H.E., Arendt B.M., Noureldin S.A., Therapondos G., Guindi M., Allard J.P. A cross-sectional study assessing dietary intake and physical activity in Canadian patients with nonalcoholic fatty liver disease vs healthy controls. J Acad Nutr Diet 2014, 114:1181-1194.
42. Anderson E.L., Howe L.D., Fraser A., Macdonald-Wallis C., Callaway M.P., Sattar N., et al. Childhood energy intake is associated with nonalcoholic fatty liver disease in adolescents. J Nutr 2015, 145:983-989.
43. Donnelly K.L., Smith C.I., Schwarzenberg S.J., Jessurun J., Boldt M.D., Parks E.J. Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease. J Clin Invest 2005, 115:1343-1351.
44. Lambert J.E., Ramos-Roman M.A., Browning J.D., Parks E.J. Increased de novo lipogenesis is a distinct characteristic of individuals with nonalcoholic fatty liver disease. Gastroenterology 2014, 146:726-735.
45. Pierce A.A., Pickens M.K., Siao K., Grenert J.P., Maher J.J. Differential hepatotoxicity of dietary and DNL-derived palmitate in the methionine-choline-deficient model of steatohepatitis. BMC Gastroenterol 2015, 15:72.
46. Malhi H., Barreyro F.J., Isomoto H., Bronk S.F., Gores G.J. Free fatty acids sensitise hepatocytes to TRAIL mediated cytotoxicity. Gut 2007, 56:1124-1131.
47. Holzer R.G., Park E.J., Li N., Tran H., Chen M., Choi C., et al. Saturated fatty acids induce c-Src clustering within membrane subdomains, leading to JNK activation. Cell 2011, 147:173-184.
48. Sharma M., Urano F., Jaeschke A. Cdc42 and Rac1 are major contributors to the saturated fatty acid-stimulated JNK pathway in hepatocytes. J Hepatol 2012, 56:192-198.
49. McGarry J.D., Mannaerts G.P., Foster D.W. A possible role for malonyl-CoA in the regulation of hepatic fatty acid oxidation and ketogenesis. J Clin Invest 1977, 60:265-270.
50. McGarry J.D., Brown N.F. The mitochondrial carnitine palmitoyltransferase system. From concept to molecular analysis. Eur J Biochem 1997, 244:1-14.
51. Sampath H., Miyazaki M., Dobrzyn A., Ntambi J.M. Stearoyl-CoA desaturase-mediates the pro-lipogenic effects of dietary saturated fat. J Biol Chem 2007, 282:2483-2493.
52. Lin J., Yang R., Tarr P.T., Wu P.H., Handschin C., Li S., et al. Hyperlipidemic effects of dietary saturated fats mediated through PGC-1beta coactivation of SREBP. Cell 2005, 120:261-273.
53. Ntambi J.M. Dietary regulation of stearoyl-CoA desaturase 1 gene expression in mouse liver. J Biol Chem 1992, 267:10925-10930.
54. Turner S.M., Roy S., Sul H.S., Neese R.A., Murphy E.J., Samandi W., et al. Dissociation between adipose tissue fluxes and lipogenic gene expression in ob/ob mice. Am J Physiol Endocrinol Metab 2007, 292:E1101-E1109.
55. Bassilian S., Ahmed S., Lim S.K., Boros L.G., Mao C.S., Lee W.N. Loss of regulation of lipogenesis in the Zucker diabetic rat. II. Changes in stearate and oleate synthesis. Am J Physiol Endocrinol Metab 2002, 282:E507-E513.
56. Duarte J.A., Carvalho F., Pearson M., Horton J.D., Browning J.D., Jones J.G., et al. A high-fat diet suppresses de novo lipogenesis and desaturation but not elongation and triglyceride synthesis in mice. J Lipid Res 2014, 55:2541-2553.
57. Delgado T.C., Pinheiro D., Caldeira M., Castro M.M., Geraldes C.F., Lopez-Larrubia P., et al. Sources of hepatic triglyceride accumulation during high-fat feeding in the healthy rat. NMR Biomed 2009, 22:310-317.
58. Brunengraber D.Z., McCabe B.J., Kasumov T., Alexander J.C., Chandramouli V., Previs S.F. Influence of diet on the modeling of adipose tissue triglycerides during growth. Am J Physiol Endocrinol Metab 2003, 285:E917-E925.
59. Baumgardner J.N., Shankar K., Hennings L., Badger T.M., Ronis M.J. A new model for nonalcoholic steatohepatitis in the rat utilizing total enteral nutrition to overfeed a high-polyunsaturated fat diet. Am J Physiol Gastrointest Liver Physiol 2008, 294:G27-G38.